The Journal of Immunology, Vol 142, Issue 1 20-27, Copyright © 1989 by American Association of Immunologists

ARTICLES

Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo

N Lycke, AK Bromander, L Ekman, U Karlsson and J Holmgren
Department of Medical Microbiology, University of Goteborg, Sweden.

Cholera toxin (CT) is a potent oral immunogen that also acts as a strong mucosal adjuvant for immune responses to related as well as unrelated Ag. To elucidate the immunomodulating effects of CT at the cellular level we have examined interactions of CT with APC and with B and T lymphocytes in vitro. CT markedly stimulated the production of IL- 1 from APC (mouse peritoneal macrophages or macrophage cell line P388D1) but did not induce Ia-Ag and had marginal, if any, effect in potentiating Ia Ag expression stimulated by rIFN-gamma on these cells. CT had differential effect on T cell proliferation in vitro, usually strongly inhibitory but on Con A-stimulated spleen cells during prolonged (greater than or equal to 5 days) culture or when added on day 4 or later to these cultures up to a two- to three-fold enhancement of proliferation was seen. CT-induced inhibition of T cell proliferation was associated with decreased production of IL-2 and anergy to exogenously added IL-2 despite apparently normal expression of IL-2R. Similar to what was found with T cells LPS-stimulated spleen B cells demonstrated both inhibition and enhancement of proliferation in the presence of CT: in high concentrations (greater than or equal to 10(-8) M) and early in culture (day 3) CT had a strong inhibitory effect on the proliferation of B cells, whereas later (day 6) and/or at lower CT concentrations (10(-9) to 10(-11) M) the proliferation was increased up to 10-fold. The net effect of CT treatment on Ig- production by LPS-stimulated spleen B cells was seen as an enhanced level of IgA and IgG but not IgM in culture supernatants. The differential effects of CT on the cells of the immune system observed in vitro may, singly or in combination, explain the immunostimulatory function of CT.

This article has been cited by other articles:

				F.-S. Quan, R. W. Compans, H. H. Nguyen, and S.-M. Kang Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization J. Virol., February 1, 2008; 82(3): 1350 - 1359. [Abstract] [Full Text] [PDF]

				S. Chatterjee, R. Neill, J. W. Shupp, R. Hammamieh, B. Ionin, and M. Jett Identification of Staphylococcal Enterotoxin B Domains Involved in Binding to Cultured Human Kidney Proximal Tubular Cells: Imparting Proliferation and Death Experimental Biology and Medicine, October 1, 2007; 232(9): 1142 - 1151. [Abstract] [Full Text] [PDF]

				A. Duverger, R. J. Jackson, F. W. van Ginkel, R. Fischer, A. Tafaro, S. H. Leppla, K. Fujihashi, H. Kiyono, J. R. McGhee, and P. N. Boyaka Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens J. Immunol., February 1, 2006; 176(3): 1776 - 1783. [Abstract] [Full Text] [PDF]

				D. S. Riminton, R. Kandasamy, D. Dravec, A. Basten, and A. G. Baxter Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease J. Immunol., January 1, 2004; 172(1): 302 - 309. [Abstract] [Full Text] [PDF]

				S. A. Fraser, L. de Haan, A. R. Hearn, H. K. Bone, R. J. Salmond, A. J. Rivett, N. A. Williams, and T. R. Hirst Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions Infect. Immun., March 1, 2003; 71(3): 1527 - 1537. [Abstract] [Full Text] [PDF]

				M. Martin, A. Sharpe, J. D. Clements, and S. M. Michalek Role of B7 Costimulatory Molecules in the Adjuvant Activity of the Heat-Labile Enterotoxin of Escherichiacoli J. Immunol., August 15, 2002; 169(4): 1744 - 1752. [Abstract] [Full Text] [PDF]

				V. Burkart, Y.-E. Kim, B. Hartmann, I. Ghiea, U. Syldath, M. Kauer, W. Fingberg, P. Hanifi-Moghaddam, S. Muller, and H. Kolb Cholera Toxin B Pretreatment of Macrophages and Monocytes Diminishes Their Proinflammatory Responsiveness to Lipopolysaccharide J. Immunol., February 15, 2002; 168(4): 1730 - 1737. [Abstract] [Full Text] [PDF]

				H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization J. Immunol., November 1, 2001; 167(9): 5386 - 5394. [Abstract] [Full Text] [PDF]

				L. Agren, E. Sverremark, L. Ekman, K. Schon, B. Lowenadler, C. Fernandez, and N. Lycke The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects J. Immunol., June 15, 2000; 164(12): 6276 - 6286. [Abstract] [Full Text] [PDF]

				D. L. Foss, M. J. Zilliox, and M. P. Murtaugh Differential Regulation of Macrophage Interleukin-1 (IL-1), IL-12, and CD80-CD86 by Two Bacterial Toxins Infect. Immun., October 1, 1999; 67(10): 5275 - 5281. [Abstract] [Full Text] [PDF]

				E. Williamson, G. M. Westrich, and J. L. Viney Modulating Dendritic Cells to Optimize Mucosal Immunization Protocols J. Immunol., October 1, 1999; 163(7): 3668 - 3675. [Abstract] [Full Text] [PDF]

				M. C. Braun, J. He, C.-Y. Wu, and B. L. Kelsall Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor beta 1 and beta 2 Chain Expression J. Exp. Med., February 1, 1999; 189(3): 541 - 552. [Abstract] [Full Text] [PDF]

				M. Marinaro, P. N. Boyaka, R. J. Jackson, F. D. Finkelman, H. Kiyono, E. Jirillo, and J. R. McGhee Use of Intranasal IL-12 to Target Predominantly Th1 Responses to Nasal and Th2 Responses to Oral Vaccines Given with Cholera Toxin J. Immunol., January 1, 1999; 162(1): 114 - 121. [Abstract] [Full Text] [PDF]

				A. Porgador, H. F. Staats, Y. Itoh, and B. L. Kelsall Intranasal Immunization with Cytotoxic T-Lymphocyte Epitope Peptide and Mucosal Adjuvant Cholera Toxin: Selective Augmentation of Peptide-Presenting Dendritic Cells in Nasal Mucosa-Associated Lymphoid Tissue Infect. Immun., December 1, 1998; 66(12): 5876 - 5881. [Abstract] [Full Text] [PDF]